Skip to main content
SpringerLink
Log in

Chronische Erweiterungen der Bronchien

Bronchiektasen — lange versteckt, immer häufiger entdeckt

  • fortbildung
  • Published:
Pneumo News Aims and scope

Bronchiektasen werden auch bei Patienten ohne Cystische Fibrose immer häufiger entdeckt. Das mag zu einem großen Teil an der verbesserten Diagnostik und der erhöhten Aufmerksamkeit für diese irreversiblen sackförmigen Ausweitungen der Bronchien liegen, in denen sich allzu gern Infektionen festsetzen. Leider bedeutet „Gefahr erkannt“ nicht immer auch „Gefahr gebannt“. Die Forschung steht hier noch ziemlich am Anfang.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
3
4

Literatur

  1. Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med 2018; 18

    Google Scholar 

  2. Lonni S, Chalmers JD, Goeminne PC et al. Etiology of Non—Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity. Ann Am Thorac Soc 2015; 12: 1764—1770

    Article  Google Scholar 

  3. Buscot M, Pottier H, Marquette C-H, Leroy S. Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis: A 10-Year Cohort Study in a French Regional University Hospital Center. Respiration 2016; 92: 1—8

    Article  Google Scholar 

  4. McShane PJ, Naureckas ET, Strek ME. Bronchiectasis in a Diverse US Population. Chest 2012; 142: 159—167

    Article  Google Scholar 

  5. Rademacher J, Ringshausen F. Non-CF-Bronchiektasen mit Fokus auf die allergische bronchopulmonale Aspergillose. Pneumologie 2013; 67: 40—49

    Article  CAS  Google Scholar 

  6. Ringshausen FC, de Roux A, Diel R et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur Respir J 2015; 46: 1805—1807

    Article  CAS  Google Scholar 

  7. Monteagudo M, Rodríguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study. Respir Med 2016; 121: 26—31.

    Article  Google Scholar 

  8. Quint JK, Millett ERC, Joshi M et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur Respir J 2016; 47: 186—193.

    Article  Google Scholar 

  9. Hill AT, Haworth CS, Aliberti S et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J 2017; 49: 1700051

    Article  Google Scholar 

  10. Chalmers JD, Goeminne P, Aliberti S et al. The Bronchiectasis Severity Index. An International Derivation and Validation Study. Am J Respir Crit Care Med 2014; 189: 576—585.

    Article  Google Scholar 

  11. Polverino E, Goeminne PC, McDonnell MJ et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50: 1700629

    Article  Google Scholar 

  12. Nährlich L, Stuhrmann-Spangenberg M, Derichs N. Handlungsempfehlung nach der Leitlinie „Diagnose der Mukoviszidose“. Monatsschr Kinderheilkd 2014; 162: 723—724.

    Article  Google Scholar 

  13. Rademacher J, Buck A, Schwerk N et al. Nasal Nitric Oxide Measurement and a Modified PICADAR Score for the Screening of Primary Ciliary Dyskinesia in Adults with Bronchiectasis. Pneumologie 2017; 71: 543—548.

    Article  CAS  Google Scholar 

  14. Wilson R, Aksamit T, Aliberti S et al. Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. Respir Med 2016; 117: 179—189.

    Article  Google Scholar 

  15. Murray MP, Govan JRW, Doherty CJ et al. A Randomized Controlled Trial of Nebulized Gentamicin in Non—Cystic Fibrosis Bronchiectasis. Am J Respir Crit Care Med 2011; 183: 491—499.

  16. Scheinberg P. A Pilot Study of the Safety and Efficacy of Tobramycin Solution for Inhalation in Patients With Severe Bronchiectasis*. CHEST J 2005; 127: 1420.

    CAS  Google Scholar 

  17. Haworth CS, Foweraker JE, Wilkinson P, Kenyon RF, Bilton D. Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection. Am J Respir Crit Care Med 2014; 189: 975—982.

    Article  Google Scholar 

  18. Drobnic ME, Suñé P, Montoro JB, Ferrer A, Orriols R. Inhaled Tobramycin in Non-Cystic Fibrosis Patients with Bronchiectasis and Chronic Bronchial Infection with Pseudomonas Aeruginosa. Ann Pharmacother 2005; 39: 39—44.

    Article  CAS  Google Scholar 

  19. Serisier DJ, Bilton D, De Soyza A et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax 2013; 68: 812—817

    Article  Google Scholar 

  20. Aksamit T, Bandel T-J, Criollo M et al. The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis. Contemp Clin Trials 2017; 58: 78—85.

    Article  Google Scholar 

  21. Wong C, Jayaram L, Karalus N et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. The Lancet 2012; 380: 660—667.

    Article  CAS  Google Scholar 

  22. Altenburg J, de Graaff CS, Stienstra Y et al. Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non—Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial. JAMA 2013; 309: 1251.

    Article  CAS  Google Scholar 

  23. Serisier DJ, Martin ML, McGuckin MA et al. Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non—Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial. JAMA 2013; 309: 1260.

    Article  CAS  Google Scholar 

  24. EMBARC - Severity assessment. https://www.bronchiectasis.eu/severity-assessment (letzter Zugriff am 19.11.2018)

Download references

Author information

Authors and Affiliations

  1. Klinik für Pneumologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland

    Isabell Pink,  Tobias Welte &  Jessica Rademacher

  2. Institut für Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    Sabine Dettmer

Authors
  1. Isabell Pink
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabine Dettmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tobias Welte
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jessica Rademacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabell Pink.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pink, I., Dettmer, S., Welte, T. et al. Bronchiektasen — lange versteckt, immer häufiger entdeckt. Pneumo News 11, 25–30 (2019). https://doi.org/10.1007/s15033-019-1129-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-019-1129-6

Search

Navigation